ArticlePDF Available

Identification of Cytochrmoe oxidase p450 in Heptocytes generated from in vitro differentiation of mouse mesenchymal stem cells Council for Innovative Research

Authors:

Abstract and Figures

This study was designed to identify the presence of cytochrome oxidase p450 (CYP3A4), in the hepatic cell lines which was generated from the in vitro differentiation of mouse bone marrow mesenchymal stem cells. Bone marrow meenchymal stem cells were first isolated by collecting both the femur and tibia of the mouse thigh bone, then exess tissue were removed and the cells were flushed from the bones and cultured under highly aseptic conditions. The isolated cells were characterized as a mesenchymal stem cells via using immunocytochemistry analysis. The characterized hepatocytes were subjected to a differentiation protocol in which the differentiation medium was contained a spesfic growth factor including (Hepatocytes growth factor (HGF), Fibroblast growth factor4 (FGF4), Oncostatin M and Dexamethasone, All theses growth factor was used for directing the BM-MSCs twards the hepatic line of cells. After three weeks of the differentiation protocol the diffrentation cells were examined for the presence of Cytochrome oxidase p450 (CYP3A4), which consider as one of the specific markers of hepatocytes. Identification eas done via two different methods first, via using the immunocytochemical analysis for the antihuman mouse CYP3A4 antibody and second by ELIZA test. The results showed a posotive reactivity of the differentiated cells towards the mouse antihuman CYP3A4 antibody as well as the eliza results showed a significant increase in the enzyme level of the cell lysate during the weeks of the differentiation experiment.
Content may be subject to copyright.
ISSN 2347-6893
1406 | P a g e J u l y 2 8 , 2 0 1 5
Identification of Cytochrmoe oxidase p450 in Heptocytes generated from
in vitro differentiation of mouse mesenchymal stem cells
Zahraa K. Zedan1 Shalal M. Hussain2 Shahlaa M. Salih 3
1Al-Nahrain University, College of Science, Deparetemnt of Biotechnology, Baghdad, Iraq
zahraa.alfahad@yahoo.com
2Al- mustansyria University , Faculty of Pharmecy, Baghdad, Iraq
dr_shalal@yahoo.com
3Al-Nahrain University, College of Sience, Department of Biotechnology, Baghdad, Iraq
shahlaam2006@yahoo.com
ABSTRACT
This study was designed to identify the presence of cytochrome oxidase p450 (CYP3A4), in the hepatic cell lines which
was generated from the in vitro differentiation of mouse bone marrow mesenchymal stem cells. Bone marrow meenchymal
stem cells were first isolated by collecting both the femur and tibia of the mouse thigh bone, then exess tissue were
removed and the cells were flushed from the bones and cultured under highly aseptic conditions. The isolated cells were
characterized as a mesenchymal stem cells via using immunocytochemistry analysis. The characterized hepatocytes were
subjected to a differentiation protocol in which the differentiation medium was contained a spesfic growth factor including
(Hepatocytes growth factor (HGF), Fibroblast growth factor4 (FGF4), Oncostatin M and Dexamethasone, All theses
growth factor was used for directing the BM-MSCs twards the hepatic line of cells. After three weeks of the differentiation
protocol the diffrentation cells were examined for the presence of Cytochrome oxidase p450 (CYP3A4), which consider as
one of the specific markers of hepatocytes. Identification eas done via two different methods first, via using the
immunocytochemical analysis for the antihuman mouse CYP3A4 antibody and second by ELIZA test. The results showed
a posotive reactivity of the differentiated cells towards the mouse antihuman CYP3A4 antibody as well as the eliza results
showed a significant increase in the enzyme level of the cell lysate during the weeks of the differentiation experiment.
Keywords: Cytochrome oxidase p450; mesenchymal stem cells; hepatocytes;
Academic Discipline And Sub-Disciplines
Stem cell technology
SUBJECT CLASSIFICATION
Regenerative medicine Classification
TYPE (METHOD/APPROACH)
Immunocytochemistry, Elisa analysis
Council for Innovative Research
Peer Review Research Publishing System
Journal of Advances in Biology
Vol. 7, No. 3
www.cirjab.com
editorsjab@gmail.com , editor@cirjab.com
ISSN 2347-6893
1407 | P a g e J u l y 2 8 , 2 0 1 5
INTRODUCTION
Cytochrome P450 3A4 (abbreviated CYP3A4) is an important enzyme in the body, mainly found in the liver and in the
intestine. Its purpose is to oxidize small foreign organic molecules (xenobiotics), such as toxins or drugs, so that they can
be removed from the body [1]. The potential ability of CYP3A4 to oxidize molecules with widely diverse in size and
chemical structure is due to its large and malleable active site of the detoxitative molecule [2]. Another intriguing feature of
CYP3A4 is the ability to accommodate more than one molecule in the substrate-binding pocket, where one molecule
serves as a substrate while another acts as a modulator of substrate metabolism. Among the substrates that exhibit
binding cooperativity with CYP3A4 are testosterone, progesterone, diazepam, α-naphthoflavone, and others [3].While
many drugs are deactivated by CYP3A4, there are also some drugs which are activated by the enzyme. Some
substances, such as grapefruit juice and some drugs, interfere with the action of CYP3A4. These substances will therefore
either amplify or weaken the action of those drugs that are modified by CYP3A4 [4].The enzyme CYP3A4 is a member of
the cytochrome P450 family of oxidizing enzymes. Several other members of this family are also involved in drug
metabolism, but CYP3A4 is the most common and the most versatile one. Like all members of this family, it is a
hemoprotein, i.e. a protein containing a heme group with an iron atom. In humans, the CYP3A4 protein is encoded by the
CYP3A4 gene, this gene is part of a cluster of cytochrome P450 genes on chromosome 7 [5].
MSCs are a type of multipotent adult stem cells that can be readily obtained from BM aspirates and expanded into large
quantities in vitro. Furthermore, MSCs possess potent immunosuppressive activities. Therefore MSCs could be used in
patients who are in need of immune modulation, as well as tissue repair, such as organ transplant recipients and patients
with severe autoimmune diseases [6]. MSCs considered as the ideal cells in the therapeutic approaches. The
differentiation of MSCs is regulated by various signals from microenvironment, which is consisting of many biological
molecules and biomechanical forces. These factors play a vital role in determining the efficacy of MSCs biology [7].
A major area of research in transplantation medicine is the potential application of stem cells in liver regeneration. This
would require well-defined and efficient protocols for directing the differentiation of stem cells into the hepatic lineage,
followed by their selective purification and proliferation in vitro.
MATERIALS AND METHODS
Experimental animals
Swiss albino mice of four to eight weeks old were obtained from the Laboratory Animal Unit of the Iraqi center for cancer
researches and medical genetics Baghdad, Iraq were used in this research. The animal housing were performen under a
clean conditions of healthy diet and acycle of 12 hrs day and light.
Isolation of bone marrow MSCs
The mouse bone marrow MSCs (mBM-MSCs) were isolated by collecting the thigh bones. The bone marrow was extruded
by clipping of the epiphyseal ends of both femur and tibia bones and flushing with Minimum essential medium (MEM)
(Sigma, St. Louis, MO), supplemented with 10% fetal bovine serum (US Biological, USA), 1% penicillin/streptomycin
(Medium A). After 24 hours, non-adherent cells and debris were removed, and the adherent cells were cultured
continuously. At near confluence, the cells were replated at 5 × 104 cells/ml [8].
Characterization of mouse MSCs
Isolated MSCs were identified from the other bone marrow cells haematopoietic stem cells using immunocytochemical
analysis, which based on the cell nature of expressing specific cell markers on their surface. These techniques are based
on the immunoreactivity of antibodies and the chemical properties of enzymes or enzyme complexes which react with
ISSN 2347-6893
1408 | P a g e J u l y 2 8 , 2 0 1 5
colorless substrate- chromogens to produce a colored end product. Initial immuno-enzymatic stains utilized the direct
method, which conjugates enzymes directly to an antibody with known antigenic specificity (primary antibody). It allowed
for the visualization of tissue antigens using a standard light microscope [13].
Induction of hepatogenic differention
In hepatogenic differentiation the 3rd passage of (2 ×104) of mBM-MSCs were used. The differentiation strategy involved
two main stages in first stage which lasted for a week the cells were cultured in a DMEM medium supplemented with 10%
FBS, 20 ng/ml (Fetal bovine serum) HGF, 20 ng/ml FGF4 (Fibroblast growth factor) and 10-7 M/L dexamethasone. At the
second stage which lasted for two weeks the same media where used as the first stage with the addition of 10 ng/ml of
oncostatin M (Sigma, USA). As a negative control, mBM-MSCs were cultured in medium without differentiation stimuli
along with the differentiation experiments in the same conditions. Cells were cultured in a humidified atmosphere of 5%
CO2 and 95% air at 37. Cultures were maintained by medium exchange every 3 d. The cell morphology was observed
under inverted microscope [6].
Identification of CYP3A4 in differentiated cells via immunocytochemical anlyais
After three weeks of differentiation, the cultured cells were washed twice with PBS and fixed with 4% paraformaldehyde
for 30-45 min at room temperature and permeabilized with 0.4% Triton X-100 (Sigma-Aldrich, St. Louis, USA) for 10 min.
After blocking with bovine serum albumin, the washed cells were incubated overnight at 4 °C with primary antibody which
is a mouse anti-human CYp3A4 (1:1000) [4]. The cells were then incubated with DAPI stain (4’,6-diamidino-2-
phenylindole; 1:1000) for nuclear staining, between each incubation, the samples were washed with PBS-0.05% Tween.
Then the counter stain heamatotoxilin stain is added. The ratio of immunopositive cells to the total number of cell nuclei
labeled with DAPI was recorded [7].
Identification of CYP3A4 in differentiated cells lysate via Elisa test
Cytochrome P450 3A4 (CYP3A4) BioAssay™ ELISA Kit (Mouse) utilizes the sandwich Enzyme Immunoassay technique
for in vitro quantative measurement of CYP3A4 in mouse, the microtiter plate provided in the detection kit has been pre-
coated with an antibody specific to CYP 3A4.Standers or samples are added to the appropriate microtiter plate wells with
a biotin-conjugated antibody specific to CYP3A4. Next, avidin conjugated to horseradish peroxidase (HRP) is added to
each microplate well and incubated. After TMB substrate solution is added, only those wells that contain CYP3A4, biotin-
conjugated antibody and enzyme-conjugated avidin will exhibit a change in color. The enzyme-substrate reaction is
terminated by the addition of sulfuric acid solution and the color change is measured spectrophotometrically at a wave
length of 450nm ± 10nm. The concentration of CYP3A4 in samples is then determined by comparing the OD of the
samples to the standard curve. The standard curve was drawn using curve expert 3.1 computer software by plotting on
the horizontal axis the cytochrome p450 concentrations of the standards and on the vertical axis the corresponding
average absorbance. To locate the concentration of cytochrome p450 in the samples, the average absorbance for each
sample on the vertical axis was located and the corresponding cytochrome p450 concentration was located on the
horizontal axis. (figure 1).
ISSN 2347-6893
1409 | P a g e J u l y 2 8 , 2 0 1 5
Figure (1-2): Standard curves for mouse cytochrome p450
Figure (1): Standard curves for mouse cytochrome p450.
Results
Characterization ofBM- MSCsMSCs were isolated with perfect confluence form bone marrow flashing and cultured in
MEM medium containing 20% of FBS in primary culture then after passaging the cells were cultured in MEM mediumwith
10% FBS. Results showed attachment of isolated MSCs to the surface of culture falcon after 24 hrs of primary culture
while MSCs showed the spindle shape by after 80% confluence. Results showed the positive reactivity for CD 90 and
CD105 in which the cells stained withDAPI stain while the negative reactivity was noticed for both hematopoietic stem cell
markers CD34 and CD45 cells and stained with heamotoxilin stain Figure (2).
Figure (2): Immunocytochemistry analysis of isolated BM-MSCs: shows the positive reaction of cells towards
CD105 and CD90 markers of cell surface and the negative reaction for CD34 and CD45 cell surface markers.
Hepatocytes differentiation
during the differentiation experiment the cultured cells were monitored via inverted microscope for
morphological changes of MSCs during the stages of differentiation of hepatocytes Figure 3 (A,B,C,D,E and F).
CD 105
CD 90
CD 34
CD 45
0
0.2
0.4
0.6
0.8
1
1.2
020 40 60 80 100 120
O.D at 450 nm
Cytochrome oxidase p450 concentration in ng/ml
ISSN 2347-6893
1410 | P a g e J u l y 2 8 , 2 0 1 5
Figure (3): Different stages of morphological patterns of hepatogenic differentiation of Mouse MSCs. A: the mesenchymal
stem cells isolated from mouse bone marrow; B: BM-MSCs under differentiation condition at day 10; C: BM-MSCs under
differentiation condition at day 16; D, E: Differentiated cells at day 19 and 21 F: cells at the end of differentiation
experiment.
Immunocytochemistry analysis of CYP3A4 of the differentiated cells
At the end of the differentiation experiments the resulting hepatocytes like cells were tested for Cytochrome oxidase p450
(CYP3A4 p450) expression, results showed that the majority of the differentiated cells (about 70% ) were stained with the
brown DAP stain (Figure 3-5 A), means these cells are positively reacted towards CYP3A4 p450 mouse anti human
primary antibody explain that the cells are positive for CYP3A4 enzyme expression, as well as some of these cells were
shown to be negatively reacted to the CYP3A4 p450 suggested that these cells may be undifferentiated cells or are not
completely differentiated to express the CYP3A4 p450 enzyme as a mature differentiated hepatocytes.
Figure (4): Immunocytochemical analysis of cytochrome oxidase p450 (CYP3A44 p450) in hepatocytes like cells. Positive
reaction in (A) in induced hepatocytes like cells, while (B) shows the negative reaction of cells against mouse antihuman
CYP3A4 p450.
Elisa assay of CYP3A4 in differentiated cells lysate
Results revealed that a significant increase in CYT3A4 concentration in hepatocyte lysate at 21 day (65.27± 0.52) ng/ml
in comparison with 14 and 7 33.0 ±0.0.72 and 16.73±0.92) ng/ml respectively (Figure 5).
ISSN 2347-6893
1411 | P a g e J u l y 2 8 , 2 0 1 5
Figure (5): Level of CYT3A4 (ng/ml) in hepatocyte lysate after differentdifferentiation period.
ACKNOWLEDGMENTS
This study was supported by the Coordination of Iraqi center of Cancer researches and medical genetics and the college
of Science/department of biotechnology/Al-Nahrain Univ.
Discussion
The differentiation mechanism of mesenchymal stem cells is guided by a number of growth factors which affected the
expression of specific genes which directed the cells towards the cell type of interest in vitro. [9].Mesenchymal stem cells
(MSCs) have because of their plasticity and mulipotency had played a promising and reliable source for hepatic cell line
for the treatment of liver diseases [10].
Although the stem cell differentiation mechanism remains unclear to date, transdifferentiation might either be induced by
stimulating with suitable media/substrates/factors, or by genetic reprogramming in vitro [11]. Fibroblast growth factors
(FGFs), are involved at an initial stage of endodermal patterning to induce hepatic fate [9] Oncostatin M, a member of the
interleukin-6 cytokine family produced by hematopoietic cells, is required from the mid-fetal to the neonatal stages and
apparently coordinates liver development and hematopoiesis in the fetus [12]. This is consistent with the fact that FGF-4
may play a role in endoderm specification, and that HGF induces differentiation of hepatocytes that are not actively
proliferating [13]. Dexamethasone has been shown to have a specific differentiation-inducing effect on primary fetal
hepatic cells towards mature hepatocytes [14].
The cytochrome P450 (P450) superfamily consists of a large number of haem-containing mono-oxygenases that play a
pivotal role in the metabolism of many drugs and carcinogens [15]. Cytochrome P450 contain isoenzymes which catalyze
he metabolism of a wide number of drugs in the liver [16]. The non -hepatic cells may also possess this kind of catabolic
enzyme (CYp3A4) but in a ratio lower than in the hepatic cells in which these cells having a major role in drug metabolism
in the liver, this why the Elisa results showed a significant increase in the level of CYP3A4 at the end of the differentiation
protocol where the cells are fully differentiated in to hepatic cell line.
From all above we conclude that the bone marrow derived mesenchymal stem cells were able to differentiates into hepatic
cell line and expressed a higher level of the catabolic enzyme CYP3A4 which is involved in the detoxification processes of
many drugs achieved by the liver.
ISSN 2347-6893
1412 | P a g e J u l y 2 8 , 2 0 1 5
References
[1] Qiu H, Mathäs M, Nestler S, Bengel C, Nem D, Gödtel-Armbrust U, Lang T, Taudien S, Burk O, Wojnowski L (2010).
"The complexity of the CYP3A4 upstream region suggests a nongenetic explanation of its expression variability".
Pharmacogenet.Genomics 20 (3).
[2]Kumar S, Qiu H, Oezguen N, Herlyn H, Halpert JR, Wojnowski L (2009). "Ligand diversity of human and chimpanzee
CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection". Drug Metab.Dispos. 37 (6):
132833.
[3] Meunier B, de Visser SP, Shaik S (2014). "Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes".
Chem. Rev. 104 (9): 394780.. [4] Caplan AI." Why are MSCs therapeutic? New data: new insight". J Pathol.;217:318
324, 2009.
[4] Sevrioukova IF, Poulos TL (2012). "Structural and mechanistic insights into the interaction of cytochrome P4503A4 with
bromoergocryptine, a type I ligand". J. Biol. Chem. 287 (5): 35107.
[5] Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T (2011). "Gene structure of CYP3A4, an
adult-specific form of cytochrome P450 in human livers, and its transcriptional control". Eur. J. Biochem. 218 (2): 585
95.
[6] Le Blanc, K. &Ringd´ en, O. (2011). Immunobiology of human mesenchymal stem cells and future use in hematopoietic
stem cell transplantation.Biology of Blood & Marrow Transplantation. 11:321334.
[7] Hwang NS, Zhang C, Hwang YS and Varghese S. "Mesenchymal stem cell differentiation and roles in regenerative
medicine". Wiley Interdiscip Rev SystBiol Med. 1,97-106, 2009.
[8] Kim TH, Bowen WC, Stolz DB, Runge D, Mars WM, Michalopoulos GK. (2005).Differential expression and distribution
of focal adhesion and cell adhesion molecules in rat hepatocyte differentiation. Exp. Cell Res. 244: 93104.
[9] Wang Y, Deng Y and Zhou GQ. "SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow
stromal cells towards ischemic brain lesion in a rat model". Brain Res; 1195: 104-112, 2008.
[10] Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Osaki, M., Kawamata, M., Kato, T., Okochi, H. and
Ochiya, T. (2008). IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after
transplantation into mice with liver injury. Stem Cells 26, 27052712.
[11] Safford KM, Hicok KC, Safford SD, Halvorsen YD, Wilkison WO, Gimble JM and Rice HE.( 2002) Neurogenic
differentiation of murine and human adipose-derived stromal cells. BiochemBiophys Res Commun.; 294:371379.
[12] Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R. et al. (2010). Human liver stem
cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 14:16051618.
[13] Wells JM, Melton DA. Early mouse endoderm is patterned by soluble factors from adjacent germ layers. Development
2000; 127: 1563-1572.
[14] Seo, M.J., Suh, S.Y., Bae, Y.C. and Jung, J.S. (2005) Differentiation of human adipose stromal cells into hepatic
lineage in vitro and in vivo. Biochem.Biophys. Res. Commun. 328, 258264.
[15] Snykers S, et al. "Sequential exposure to cytokines reflecting embryogenesis: the key for in vitro differentiation of
adult bone marrow stem cells into functional hepatocyte-like cells". ToxicolSci; 94: 330-341, 2006.
[16] King-Wah C, Toshiaki N., and Kuang-Den C. Cytochrome P450 in living donor liverTransplantation,Journal of
Biomedical Science 22:32 . 2015.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Cytochrome P450 metabolizes many drugs in the liver. Three genotypes of CYP2C19 with extensive, intermediate, and poor metabolizing activity, respectively, have been identified in peripheral blood of transplant recipients and new liver grafts in living donor liver transplantation (LDLT). The expression of the final genotype in liver graft biopsies depends on the donor, whereas the expression in peripheral blood mononuclear cells depends on the recipient. The metabolizing isoenzyme of the major anti-rejection agents passes through CYP3A4, CYP3A5 and MDR1, which have also been identified to have similar biological characteristics as genotype of CYP2C19 in liver tissue. Recently, pyrosequencing has been used to investigate the expressions of different genotypes in liver grafts in LDLT. This review focuses on recent findings regarding the biological expressions of the CYP2C19, CYP3A4, CYP3A5 and MRD1 genotypes in liver grafts before and after LDLT. The application of pyrosequencing may be beneficial in further research on liver transplantation. Laser capture microdissection of hepatocytes in liver grafts may be a direction for future research.
Article
Full-text available
Cytochrome P4503A4 (CYP3A4), a major human drug-metabolizing enzyme, is responsible for the oxidation and clearance of the majority of administered drugs. One of the CYP3A4 substrates is bromoergocryptine (BEC), a dopamine receptor agonist prescribed for the inhibition of prolactin secretion and treatment of Parkinson disease, type 2 diabetes, and several other pathological conditions. Here we present a 2.15 Å crystal structure of the CYP3A4-BEC complex in which the drug, a type I heme ligand, is bound in a productive mode. The manner of BEC binding is consistent with the in vivo metabolite analysis and identifies the 8' and 9' carbons of the proline ring as the primary sites of oxidation. The crystal structure predicts the importance of Arg(212) and Thr(224) for binding of the tripeptide and lysergic moieties of BEC, respectively, which we confirmed experimentally. Our data support a three-step BEC binding model according to which the drug binds first at a peripheral site without perturbing the heme spectrum and then translocates into the active site cavity, where formation of a hydrogen bond between Thr(224) and the N1 atom of the lysergic moiety is followed by a slower conformational readjustment of the tripeptide group modulated by Arg(212).
Article
Full-text available
Several studies indicate that adult stem cells may improve the recovery from acute tissue injury. It has been suggested that they may contribute to tissue regeneration by the release of paracrine factors promoting proliferation of tissue resident cells. However, the factors involved remain unknown. In the present study we found that microvesicles (MVs) derived from human liver stem cells (HLSC) induced in vitro proliferation and apoptosis resistance of human and rat hepatocytes. These effects required internalization of MVs in the hepatocytes by an alpha(4)-integrin-dependent mechanism. However, MVs pre-treated with RNase, even if internalized, were unable to induce hepatocyte proliferation and apoptosis resistance, suggesting an RNA-dependent effect. Microarray analysis and quantitative RT-PCR demonstrated that MVs were shuttling a specific subset of cellular mRNA, such as mRNA associated in the control of transcription, translation, proliferation and apoptosis. When administered in vivo, MVs accelerated the morphological and functional recovery of liver in a model of 70% hepatectomy in rats. This effect was associated with increase in hepatocyte proliferation and was abolished by RNase pre-treatment of MVs. Using human AGO2, as a reporter gene present in MVs, we found the expression of human AGO2 mRNA and protein in the liver of hepatectomized rats treated with MVs. These data suggested a translation of the MV shuttled mRNA into hepatocytes of treated rats. In conclusion, these results suggest that MVs derived from HLSC may activate a proliferative program in remnant hepatocytes after hepatectomy by a horizontal transfer of specific mRNA subsets.
Article
Full-text available
For currently unknown reasons, the evolution of CYP3A4 underwent acceleration in the human lineage after the split from chimpanzee. We investigated the significance of this event by comparing Escherichia coli-expressed CYP3A4 from humans, chimpanzee, and their most recent common ancestor. The expression level of chimpanzee CYP3A4 was approximately 50% of the human CYP3A4, whereas ancestral CYP3A4 did not express in E. coli. Steady-state kinetic analysis with 7-benzyloxyquinoline, 7-benzyloxy-4-(trifluoromethyl)coumarin (7-BFC), and testosterone showed no significant differences between human and chimpanzee CYP3A4. Upon addition of alpha-naphthoflavone (25 microM), human CYP3A4 showed a slightly decreased substrate concentration at which 50% of the maximal rate V(max) is reached for 7-BFC, whereas chimpanzee CYP3A4 showed a >2-fold increase. No significant differences in inhibition/activation were found for a panel of 43 drugs and endogenous compounds, suggesting that the wide substrate spectrum of human CYP3A4 precedes the human-chimpanzee split. A striking exception was the hepatotoxic secondary bile acid lithocholic acid, which at saturation caused a 5-fold increase in 7-BFC debenzylation by human CYP3A4 but not by chimpanzee CYP3A4. Mutagenesis of human CYP3A4 revealed that at least four of the six amino acids positively selected in the human lineage contribute to the activating effect of lithocholic acid. In summary, the wide functional conservation between chimpanzee and human CYP3A4 raises the prospect that phylogenetically more distant primate species such as rhesus and squirrel monkey represent suitable models of the human counterpart. Positive selection on the human CYP3A4 may have been triggered by an increased load of dietary steroids, which led to a novel defense mechanism against cholestasis.
Article
CYP3A4 is the adult-specific form of cytochrome P450 in human livers [Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K. & Kamataki, T. (1990) Biochemistry 29, 4430–4433]. The sequences of three genomic clones for CYP3A4 were analyzed for all exons, exon-intron junctions and the 5′-flanking region from the major transcription site to nucleotide position -1105, and compared with those of the CYP3A7 gene, a fetal-specific form of cytochrome P450 in humans. The results showed that the identity of 5′-flanking sequences between CYP3A4 and CYP3A7 genes was 91%, and that each 5′-flanking region had characteristic sequences termed as NFSE (P450NF-specific element) and HFLaSE (P450HFLa specific element), respectively. A basic transcription element (BTE) also lay in the 5′-flanking region of the CYP3A4 gene as seen in many CYP genes [Yanagida, A., Sogawa, K., Yasumoto, K. & Fujii-Kuriyama, Y. (1990) Mol. Cell. Biol. 10, 1470–1475]. The BTE binding factor (BTEB) was present in both adult and fetal human livers. To examine the transcriptional activity of the CYP3A4 gene, DNA fragments in the 5′-flanking region of the gene were inserted in front of the simian virus 40 promoter and the chloramphenicol acetyltransferase structural gene, and the constructs were transfected in HepG2 cells. The analysis of the chloramphenicol acetyltransferase activity indicated that (a) specific element(s) which could bind with a factor(s) in livers was present in the 5′-flanking region of the CYP3A4 gene to show the transcriptional activity.
Article
Adult stem cells with multi or unipotent differentiation potential are present in almost all tissues of adult organisms. The main function of these stem cells is to support normal repair and rejuvenation of diseased and aging tissues. Mesenchymal stem cells (MSCs) isolated from the bone marrow have the potential to differentiate into multiple connective tissues. Advancements in understanding tissue specific differentiation of MSCs in conjunction with global genomic and proteomic profiling of MSCs have not only provided insights into their biology but also made MSC based clinical trials a reality for treating various debilitating diseases and genetic disorders. The emerging evidence that MSCs are immunosuppressive makes them an even more attractive candidate for regenerative medicine as rejections of transplants by the recipient could be a limiting step for moving the stem cells based therapies from “bedside to bed side.” To a large extent the therapeutic potential of MSCs is attributed to their differentiation ability. The fate and commitment of MSCs are regulated by various instructive signals from their immediate vicinity or microenvironment, which comprises many biological molecules (soluble and insoluble) and biomechanical forces. These biochemical and biophysical factors play a pivotal role in determining the efficacy of MSC differentiation and their contribution to the repair process. In this review, we discuss the characteristics of MSCs, their differentiation potential toward different skeletal tissues (cartilage and bone), and their emerging role in regenerative medicine. Copyright © 2009 John Wiley & Sons, Inc. For further resources related to this article, please visit the WIREs website.
Article
Adult marrow-derived mesenchymal stem cells (MSCs) are able to differentiate into bone, cartilage, muscle, marrow stroma, tendon-ligament, fat and other connective tissues. The questions can be asked, what do MSCs do naturally and where is the MSC niche? New insight and clinical experience suggest that MSCs are naturally found as perivascular cells, summarily referred to as pericytes, which are released at sites of injury, where they secrete large quantities of bioactive factors that are both immunomodulatory and trophic. The trophic activity inhibits ischaemia-caused apoptosis and scarring while stimulating angiogenesis and the mitosis of tissue intrinsic progenitor cells. The immunomodulation inhibits lymphocyte surveillance of the injured tissue, thus preventing autoimmunity, and allows allogeneic MSCs to be used in a variety of clinical situations. Thus, a new, enlightened era of experimentation and clinical trials has been initiated with xenogenic and allogeneic MSCs.
Article
Hepatocytes in primary culture enter into clonal proliferation in the chemically defined hepatocyte growth medium in the presence of hepatocyte growth factor and epidermal growth factor. Hepatocyte proliferation is associated with loss of differentiated gene expression. Overlay of matrix derived from Engelbreth-Holm-Swarm mouse sarcoma (Matrigel) on proliferating hepatocytes induces reexpression of the hepatic differentiation marker genes. To explore the role of matrix in the differentiation process of hepatocytes, we examined the mRNAs of fibronectin, vitronectin, and entactin in proliferating hepatocytes and Matrigel-treated hepatocytes. Fibronectin mRNA increased in proliferating hepatocytes at days 2-10 and then decreased; however, vitronectin mRNA disappeared in proliferating hepatocytes and was reexpressed in Matrigel-treated hepatocytes. We also found that focal adhesion kinase and paxillin were strongly increased in Matrigel-treated hepatocytes, and E-cadherin and beta-catenin slightly increased in Matrigel-treated hepatocytes, suggesting that both cell-to-extracellular matrix and cell-to-cell interactions may be an essential part of hepatocyte differentiation. To evaluate the distribution of focal adhesion associated molecules and cell-to-cell adhesion molecules, Triton X-100 soluble and insoluble fractions were examined at days 8, 9, 10, and 11 in proliferating hepatocytes and Matrigel-treated cells. We found that E-cadherin in Triton X-100 insoluble fractions dramatically decreased in Matrigel-treated hepatocytes; however, beta-catenin strongly increased in Triton X-100 soluble fractions of Matrigel-treated hepatocytes. These results suggest that the distribution of both focal adhesion associated molecules and cell adhesion molecules are reorganized during the process of differentiation induced by overlay of Matrigel.
Article
Endoderm that forms the respiratory and digestive tracts is a sheet of approximately 500-1000 cells around the distal cup of an E7.5 mouse embryo. Within 2 days, endoderm folds into a primitive gut tube from which numerous organs will bud. To characterize the signals involved in the developmental specification of this early endoderm, we have employed an in vitro assay using germ layer explants and show that adjacent germ layers provide soluble, temporally specific signals that induce organ-specific gene expression in endoderm. Furthermore, we show that FGF4 expressed in primitive streak-mesoderm can induce the differentiation of endoderm in a concentration-dependent manner. We conclude that the differentiation of gastrulation-stage endoderm is directed by adjacent mesoderm and ectoderm, one of the earliest reported patterning events in formation of the vertebrate gut tube.
Article
The identification of cells capable of neuronal differentiation has great potential for cellular therapies. We examined whether murine and human adipose-derived adult stem (ADAS) cells can be induced to undergo neuronal differentiation. We isolated ADAS cells from the adipose tissue of adult BalbC mice or from human liposuction tissue and induced neuronal differentiation with valproic acid, butylated hydroxyanisole, insulin, and hydrocortisone. As early as 1-3 h after neuronal induction, the phenotype of ADAS cells changed towards neuronal morphology. Following neuronal induction, muADAS cells displayed immunocytochemical staining for GFAP, nestin and NeuN and huADAS cells displayed staining for intermediate filament M, nestin, and NeuN. Following neuronal induction of murine and human ADAS cells, Western blot analysis confirmed GFAP, nestin, and NeuN protein expression. Pretreatment with EGF and basic FGF augmented the neuronal differentiation of huADAS cells. The neuronal differentiation of stromal cells from adipose tissue has broad biological and clinical implications.